News & Events


Korea's first AI medical device MFDS approval is just around the corner.

Korea's first Artificial Intelligence (AI) diagnostic support system has been approved. As early...

CEO of VUNO, appointed as a member of PACST

Yeha Lee, Ph.D., the CEO of VUNO, has been appointed as one of 12 members of Presidential...

Successful exhibit at RSNA2017

VUNO participated in the RSNA this year for the second time, and introduced various AI-based...

VUNO X EnvoyAI partnership announcement at RSNA 2017

We are happy to officially announce our partnership with EnvoyAI, a platform provider for...

KFDA guidelines for big data/AI based medical devices

VUNO has participated in the process of building the KFDA guidelines for big/data and AI based...

NVIDIA Deep learning Day

VUNO’s CTO Kyuhwan Jung and CSO HyunJun Kim presented at the Nvidia Deep Learning Day. In the...

Presented at the Deview event

As the sole presenter in the area of AI application in medicine, our software engineer,...

BoneAge to become the first AI based software to receive approval for clinical trials

VUNO-Med BoneAge is the first AI based diagnostic device to receive approval for clinical trials...

Bone Age Results published in AJR and AuntMinnie

Our VUNO-Med BoneAge product is currently going through clinical trials for KFDA clearance, and...

WELCOME!

Thanks for subscribing to our newsletter.